AWS Summit: A Peek at the ‘One FDA’ Plan to Modernize Tech Procurement
Acquisition leader Joseph Montgomery shares how AI and cloud technologies informed the agency’s new strategy.
The Food and Drug Administration recently released a new acquisition strategy that aims to transform how the agency buys technology to impact multiple mission areas. In an interview with FDA Office of Enterprise Portfolio Management Director Joseph Montgomery at AWS Summit, he highlights the importance of this strategy to create a “one FDA” ecosystem that prioritizes advanced technology and keeping pace with IT innovation.
Montgomery also highlights how he’s thinking about artificial intelligence, cybersecurity and cloud to impact financial operations (FinOps) and ultimately support FDA’s modernization goals.
Check out our full conference coverage.
This is a carousel with manually rotating slides. Use Next and Previous buttons to navigate or jump to a slide with the slide dots
-
Lawmakers Weigh Frontier AI Safety Next Steps From Joint Accord
Some tech stakeholders said limiting unintended consequences of AI agents means the industry’s incentive structure has to change.
-
HHS Looks to Centralize IT Buying, Speed Access to Emerging Tech
HHS is centralizing IT procurement while pursuing faster acquisition tools for AI and other emerging technologies.
9m watch -
Intel Chief Jay Clayton Heads ‘Super Intelligence Force’ as AI Czar
President Donald Trump names DNI Jay Clayton White House AI czar to lead a new Super Intelligence Force coordinating federal AI efforts.
3m read -
VA Pharmacy Upgrades Bring New AI Capabilities to EHRs
The agency incorporated feedback from pharmacists in tech upgrades that add AI capabilities and streamline prescription workflows.
3m read
